156 related articles for article (PubMed ID: 9914222)
1. Immunotherapy of allergy: anergy, deletion, and immune deviation.
Rolland J; O'Hehir R
Curr Opin Immunol; 1998 Dec; 10(6):640-5. PubMed ID: 9914222
[TBL] [Abstract][Full Text] [Related]
2. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K
J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918
[TBL] [Abstract][Full Text] [Related]
3. IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy.
Akdis CA; Blaser K
FASEB J; 1999 Apr; 13(6):603-9. PubMed ID: 10094921
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy--anergy, deviation or suppression?
Smith W; Sly PD
Clin Exp Allergy; 1998 Aug; 28(8):911-6. PubMed ID: 9756192
[No Abstract] [Full Text] [Related]
5. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.
Prickett SR; Rolland JM; O'Hehir RE
Clin Exp Allergy; 2015 Jun; 45(6):1015-26. PubMed ID: 25900315
[TBL] [Abstract][Full Text] [Related]
6. Immunologic changes associated with allergen immunotherapy.
Durham SR; Till SJ
J Allergy Clin Immunol; 1998 Aug; 102(2):157-64. PubMed ID: 9723654
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of allergen-specific antibodies in allergy and specific immunotherapy.
Blaser K; Akdis CA; Faith A
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):243-51; discussion 252. PubMed ID: 11487881
[TBL] [Abstract][Full Text] [Related]
8. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
[TBL] [Abstract][Full Text] [Related]
9. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens.
Akdis CA; Blaser K
Microbes Infect; 2001 Sep; 3(11):891-8. PubMed ID: 11564436
[TBL] [Abstract][Full Text] [Related]
10. Peptide induced anergy of human allergen-specific T cells.
Yssel H; Fasler S; Aversa G; de Vries JE
Adv Exp Med Biol; 1996; 409():405-10. PubMed ID: 9095274
[No Abstract] [Full Text] [Related]
11. High dose allergen stimulation of T cells from house dust mite-allergic subjects induces expansion of IFN-gamma+ T Cells, apoptosis of CD4+IL-4+ T cells and T cell anergy.
Gardner LM; O'Hehir RE; Rolland JM
Int Arch Allergy Immunol; 2004 Jan; 133(1):1-13. PubMed ID: 14646373
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens.
Akdis CA; Joss A; Akdis M; Blaser K
Int Arch Allergy Immunol; 2001; 124(1-3):180-2. PubMed ID: 11306962
[TBL] [Abstract][Full Text] [Related]
13. Immunologic mechanisms of allergen-specific immunotherapy.
Akdis CA; Blaser K
Adv Exp Med Biol; 2001; 495():247-59. PubMed ID: 11774574
[No Abstract] [Full Text] [Related]
14. [Exploration of mechanisms underlying T-cell anergy induced by immunotherapy in allergic murine asthma model].
Cheng XM; Qian GS; Wang CZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jul; 21(4):482-5. PubMed ID: 15989797
[TBL] [Abstract][Full Text] [Related]
15. [Principles of specific immunotherapy of IgE-induced allergic reactions].
Akdis CA; Blaser K
Ther Umsch; 2001 May; 58(5):274-7. PubMed ID: 11407227
[TBL] [Abstract][Full Text] [Related]
16. The role of interleukin 10 in the regulation of allergic immune responses.
Bellinghausen I; Knop J; Saloga J
Int Arch Allergy Immunol; 2001 Oct; 126(2):97-101. PubMed ID: 11729346
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a multi-epitopic recombinant allergen induces specific immune deviation via T-cell anergy.
Cao Y; Yang M; Luo Z; Mohapatra SS
Immunology; 1997 Jan; 90(1):46-51. PubMed ID: 9038711
[TBL] [Abstract][Full Text] [Related]
18. Does allergen immunotherapy alter the natural course of allergic disorders?
Yang X
Drugs; 2001; 61(3):365-74. PubMed ID: 11293647
[TBL] [Abstract][Full Text] [Related]
19. SPIREs: a new horizon for allergic disease treatment?
Worm M
Expert Rev Clin Immunol; 2015; 11(11):1173-5. PubMed ID: 26166009
[TBL] [Abstract][Full Text] [Related]
20. Current developments for improving efficacy of allergy vaccines.
Sandrini A; Rolland JM; O'Hehir RE
Expert Rev Vaccines; 2015; 14(8):1073-87. PubMed ID: 26013124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
